These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15480836)

  • 1. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress.
    Mytilineou C; McNaught KS; Shashidharan P; Yabut J; Baptiste RJ; Parnandi A; Olanow CW
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1237-51. PubMed ID: 15480836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
    McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
    Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures.
    Reaney SH; Johnston LC; Langston WJ; Di Monte DA
    Exp Neurol; 2006 Dec; 202(2):434-40. PubMed ID: 16920101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
    McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
    J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sleep changes during degeneration of neurons in the substantia nigra induced by inhibitor of proteasomes lactacystin in rats].
    Pastukhov IuF; Chesnokova AIu; Iakimchuk AA; Ekimova IV; Romanova IV; Khudik KA
    Ross Fiziol Zh Im I M Sechenova; 2010 Dec; 96(12):1190-202. PubMed ID: 21473106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
    Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition.
    Miwa H; Kubo T; Suzuki A; Nishi K; Kondo T
    Neurosci Lett; 2005 May 20-27; 380(1-2):93-8. PubMed ID: 15854758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells.
    Ahn TB; Jeon BS
    Brain Res; 2006 May; 1087(1):159-67. PubMed ID: 16626658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition.
    Rideout HJ; Lang-Rollin IC; Savalle M; Stefanis L
    J Neurochem; 2005 Jun; 93(5):1304-13. PubMed ID: 15934949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition in medaka brain induces the features of Parkinson's disease.
    Matsui H; Ito H; Taniguchi Y; Inoue H; Takeda S; Takahashi R
    J Neurochem; 2010 Oct; 115(1):178-87. PubMed ID: 20649841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson's disease in rats.
    Lorenc-Koci E; Lenda T; Antkiewicz-Michaluk L; Wardas J; Domin H; Smiałowska M; Konieczny J
    Neurochem Int; 2011 Jun; 58(7):839-49. PubMed ID: 21419185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
    McNaught KS; Björklund LM; Belizaire R; Isacson O; Jenner P; Olanow CW
    Neuroreport; 2002 Aug; 13(11):1437-41. PubMed ID: 12167769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis.
    Yew EH; Cheung NS; Choy MS; Qi RZ; Lee AY; Peng ZF; Melendez AJ; Manikandan J; Koay ES; Chiu LL; Ng WL; Whiteman M; Kandiah J; Halliwell B
    J Neurochem; 2005 Aug; 94(4):943-56. PubMed ID: 15992382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of oxidized proteins after oxygen-glucose deprivation in rat cortical neurons is mediated by the proteasome.
    Weih M; Schmitt M; Gieche J; Harms C; Ruscher K; Dirnagl U; Grune T
    J Cereb Blood Flow Metab; 2001 Sep; 21(9):1090-6. PubMed ID: 11524613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
    Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
    J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
    Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
    Li X; Yang D; Li L; Peng C; Chen S; Le W
    Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration.
    Li X; Du Y; Fan X; Yang D; Luo G; Le W
    J Neuropathol Exp Neurol; 2008 Oct; 67(10):933-44. PubMed ID: 18800014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.